Accelerate Diagnostics
AXDX
AXDX was delisted on the 14th of May, 2025.
71 hedge funds and large institutions have $232M invested in Accelerate Diagnostics in 2014 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 31 increasing their positions, 20 reducing their positions, and 12 closing their positions.
55% more repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 20
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9% less call options, than puts
Call options by funds: $3.51M | Put options by funds: $3.86M
5% less funds holding
Funds holding: 75 → 71 (-4)
13% less capital invested
Capital invested by funds: $265M → $232M (-$33.3M)
33% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MGM
Miura Global Management
New York
|
+$4.86M |
| 2 |
SM
Selkirk Management
Chatham,
New Jersey
|
+$3.22M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.18M |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$1.73M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$1.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$3.12M |
| 2 |
SCM
Sandler Capital Management
New York
|
-$1.42M |
| 3 |
Millennium Management
New York
|
-$993K |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$731K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$641K |
AXDX Hedge Fund Activity: Q3 2014 in Review
71 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Accelerate Diagnostics (AXDX) for Q3 2014, worth a combined $232M — down 13% from $265M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of AXDX and 8 opened new positions — a net loss of 4 holders — while 20 trimmed existing stakes and 31 added.
The largest buyer was Miura Global Management, opening a new position worth an estimated $4.86M. The largest seller was Jane Street, exiting entirely with an estimated $3.12M sold.
- 71 institutional investors held Accelerate Diagnostics (AXDX) as of Q3 2014, down from 75 in Q2 2014.
- Funds reported $232M of Accelerate Diagnostics stock for Q3 2014, down 13% quarter-over-quarter.
- 8 funds opened new Accelerate Diagnostics positions in Q3 2014 and 12 closed out, a net change of -4 holders.
- The largest Accelerate Diagnostics buyer in Q3 2014 was Miura Global Management, an estimated $4.86M added.
- The largest Accelerate Diagnostics seller in Q3 2014 was Jane Street, an estimated $3.12M sold.
Based on aggregated 13F filings for Q3 2014.